05 | MD Anderson Cancer Center

Ultrasound-guided microbubbles boost immunotherapy efficacy

May 30, 2022

Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform...

MD Anderson Research Highlights: ASCO 2022 Special Edition

BY Clayton Boldt

May 26, 2022

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and...

MD Anderson Research Highlights for May 18, 2022

BY Clayton Boldt

May 18, 2022

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and...

Adolescent and young adult leukemia survivors have shorter life...

May 13, 2022

Researchers at The University of Texas MD Anderson Cancer Center have discovered that adolescent and young adult (AYA) cancer...

TJ Gan, M.D., to join MD Anderson as Division Head of...

BY Rolaynne Kimmons

May 11, 2022

The University of Texas MD Anderson Cancer Center today announced that Tong Joo (TJ) Gan, M.D., has been named Division Head of...

Targeting interleukin-6 could help relieve immunotherapy...

BY Meagan Raeke

May 09, 2022

Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse...

MD Anderson Research Highlights for May 4, 2022

BY Clayton Boldt

May 04, 2022

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...

Newsroom

May 2022 Archive

Ultrasound-guided microbubbles boost immunotherapy efficacy

MD Anderson Research Highlights: ASCO 2022 Special Edition

MD Anderson Research Highlights for May 18, 2022

Adolescent and young adult leukemia survivors have shorter life...

TJ Gan, M.D., to join MD Anderson as Division Head of...

Targeting interleukin-6 could help relieve immunotherapy...

MD Anderson Research Highlights for May 4, 2022

Help #EndCancer

Newsroom

May 2022 Archive

Ultrasound-guided microbubbles boost immunotherapy efficacy

MD Anderson Research Highlights: ASCO 2022 Special Edition

MD Anderson Research Highlights for May 18, 2022

Adolescent and young adult leukemia survivors have shorter life...

TJ Gan, M.D., to join MD Anderson as Division Head of...

Targeting interleukin-6 could help relieve immunotherapy...

MD Anderson Research Highlights for May 4, 2022

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson